High-Tech-Gründerfonds, the Germany state- and corporate-backed fund, and the Thüringen Foundation for Technology Innovation, and Research [Stift] have invested €700,000 ($1m) in JeNaCell, a biomaterial spin-off of the Friedrich Schiller University Jena (FSU), on 12 October. JeNaCell’s biomaterial (pictured) can be used for making medical and cosmetic products, suitable for treating poorly healing wounds, as…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
